schizandrin a has been researched along with resveratrol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Chauhan, S; Kumar, A | 1 |
| Granchi, C; Minutolo, F | 1 |
2 review(s) available for schizandrin a and resveratrol
| Article | Year |
|---|---|
How much successful are the medicinal chemists in modulation of SIRT1: A critical review.
Topics: Animals; Chemistry, Pharmaceutical; Drug Discovery; Enzyme Activation; Histone Deacetylase Inhibitors; Humans; Sirtuin 1 | 2016 |
Activators of Sirtuin-1 and their Involvement in Cardioprotection.
Topics: Benzimidazoles; Cardiotonic Agents; Cardiovascular Diseases; Cyclooctanes; Ginsenosides; Heterocyclic Compounds, 4 or More Rings; Humans; Lignans; Polycyclic Compounds; Resveratrol; Sirtuin 1 | 2018 |
1 other study(ies) available for schizandrin a and resveratrol
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |